AbbVie Inc. - Significant Ownership

Signature - Title
AbbVie Inc. - Scott T. Reents, Executive Vice President, Chief Financial Officer
Location
North Chicago, IL
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by AbbVie Inc..

Significant Ownership of AbbVie Inc.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
XLO Xilio Therapeutics, Inc. Common Stock, par value $0.0001 per share 9% $3.96M 4.35M AbbVie Inc. Feb 11, 2025

Schedules 13D/G Reported by AbbVie Inc.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.